Open access · CC-BY
via OpenAlex
The interplay between autophagy and ROS in tumorigenesis
Sameera Kongara, Vassiliki Karantza
Frontiers in Oncology · 2012 · ▲ 187 citations
Mitochondrial dysfunction
Altered intercellular communication
Chronic inflammation
Disabled macroautophagy
Human
Mouse
Review
Abstract
Reactive oxygen species (ROS) at physiological levels are important cell signaling molecules. However, aberrantly high ROS are intimately associated with disease and commonly observed in cancer. Mitochondria are primary sources of intracellular ROS, and their maintenance is essential to cellular health. Autophagy(definition), an evolutionarily conserved process whereby cytoplasmic components are delivered to lysosomes for degradation, is responsible for mitochondrial turnover and removal of damaged mitochondria. Impaired autophagy is implicated in many pathological conditions, including neurological disorders, inflammatory bowel disease, diabetes, aging, and cancer. The first reports connecting autophagy to cancer showed that allelic loss of the essential autophagy gene BECLIN1 (BECN1) is prevalent in human breast, ovarian, and prostate cancers and that Becn1(+) (/) (-) mice develop mammary gland hyperplasias, lymphomas, lung and liver tumors. Subsequent studies demonstrated that Atg5(-/-) and Atg7(-/-) livers give rise to adenomas, Atg4C(-/-) mice are susceptible to chemical carcinogenesis, and Bif1(-/-) mice are prone to spontaneous tumors, indicating that autophagy defects promote tumorigenesis. Due to defective mitophagy, autophagy-deficient cells accumulate damaged mitochondria and deregulated ROS levels, which likely contribute to their tumor-initiating capacity. However, the role of autophagy in tumorigenesis is complex, as more recent work also revealed tumor dependence on autophagy: autophagy-competent mutant-Ras-expressing cells form tumors more efficiently than their autophagy-deficient counterparts; similarly, FIP200 deficiency suppresses PyMT-driven mammary tumorigenesis. These latter findings are attributed to the fact that tumors driven by powerful oncogenes have high metabolic demands catered to by autophagy. In this review, we discuss the relationship between ROS and autophagy and summarize our current knowledge on their functional interactions in tumorigenesis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fonc.2012.00171
- Canonical
- link ↗
- Fetched
- 2026-09-24 MST
Cite this
APA
Kongara, S., & Karantza, V. (2012). The interplay between autophagy and ROS in tumorigenesis. <em>Frontiers in Oncology</em>. https://doi.org/10.3389/fonc.2012.00171
Vancouver
Kongara S, Karantza V. The interplay between autophagy and ROS in tumorigenesis. Frontiers in Oncology. 2012. doi:10.3389/fonc.2012.00171.
BibTeX
@article{sameera2012Theint,
title = {The interplay between autophagy and ROS in tumorigenesis},
author = {Sameera Kongara and Vassiliki Karantza},
journal = {Frontiers in Oncology},
year = {2012},
doi = {10.3389/fonc.2012.00171},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Preprints.org 2024
Preprint · CC-BY
Illuminating Intercellular Autophagy: A Comprehensive Review of Cell Non-Autonomous Autophagy
Preprints.org 2024
Preprint · CC-BY
Illuminating Intercellular Autophagy: A Comprehensive Review of Cell Non-Autonomous Autophagy
International Journal of Molecular Sciences 2020
Open access · CC-BY
Autophagy and Autophagy-Related Diseases: A Review
Communications Biology 2024
Open access · CC-BY
Cellular and molecular roles of reactive oxygen species in wound healing
Endocrinology 2020
Open access · CC0
Mitochondrial Dysfunction in Obesity and Reproduction
The EMBO Journal 2021
Open access · CC-BY